Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival.

Skov BG, Krasnik M, Lantuejoul S, Skov T, Brambilla E.

J Thorac Oncol. 2008 Dec;3(12):1410-5. doi: 10.1097/JTO.0b013e31818e0dd4.

2.
3.

[Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].

Correia Sda S, Pinto C, Bernardo J.

Acta Med Port. 2014 Nov-Dec;27(6):749-54. Epub 2014 Dec 30. Portuguese.

4.

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S.

J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d.

5.

Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.

Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N.

J Thorac Cardiovasc Surg. 2005 Apr;129(4):825-30.

6.

Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.

Nakamura S, Fukui T, Taniguchi T, Usami N, Kawaguchi K, Ishiguro F, Hirakawa A, Yokoi K.

J Thorac Oncol. 2013 Dec;8(12):1551-7. doi: 10.1097/JTO.0000000000000020.

7.

[Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].

Langfort R, Rudziński P, Burakowska B.

Pneumonol Alergol Pol. 2010;78(1):33-46. Review. Polish.

8.

Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.

Lee JG, Lee CY, Bae MK, Park IK, Kim DJ, Kim KD, Chung KY.

J Thorac Oncol. 2008 Dec;3(12):1421-6. doi: 10.1097/JTO.0b013e31818e0dbd.

9.

Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.

Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.

Cancer. 2005 Mar 15;103(6):1154-64.

10.

Bronchial carcinoid tumors: nodal status and long-term survival after resection.

Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, Facciolo F, Martelli M.

Ann Thorac Surg. 2004 May;77(5):1781-5.

PMID:
15111186
11.

The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.

Sakao Y, Okumura S, Mingyon M, Uehara H, Ishikawa Y, Nakagawa K.

J Thorac Oncol. 2011 Mar;6(3):494-9. doi: 10.1097/JTO.0b013e31820b8891.

12.

Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?

Wei S, Asamura H, Kawachi R, Sakurai H, Watanabe S.

J Thorac Oncol. 2011 Feb;6(2):310-8. doi: 10.1097/JTO.0b013e3181ff9b45.

13.

The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung.

Marchevsky AM, Qiao JH, Krajisnik S, Mirocha JM, McKenna RJ.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):551-7.

14.

[Trends in prognostic factors for neuroendocrine lung tumors].

García-Yuste M, Molins L, Matilla JM, González-Aragoneses F, López-Pujol J, Ramos G, de la Torre M; Estudio Multicéntrico Español de los Tumores Neuroendocrinos del Pulmón de la Sociedad Española de Neumología y Cirurgía Torácica (EMETNE-SEPAR).

Arch Bronconeumol. 2007 Oct;43(10):549-56. Spanish.

15.

Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.

Kao HL, Chang WC, Li WY, Chia-Heng Li A, Fen-Yau Li A.

Am J Surg Pathol. 2012 Feb;36(2):185-92. doi: 10.1097/PAS.0b013e318236d822.

PMID:
22082601
16.

Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.

Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM.

Cancer. 2009 Feb 15;115(4):851-8. doi: 10.1002/cncr.23985.

17.

Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients.

Matsumura Y, Hishida T, Shimada Y, Ishii G, Aokage K, Yoshida J, Nagai K.

J Thorac Oncol. 2014 Mar;9(3):337-44. doi: 10.1097/JTO.0000000000000073.

18.

Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.

Saji H, Tsuboi M, Yoshida K, Kato Y, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N.

J Thorac Oncol. 2011 Nov;6(11):1865-71. doi: 10.1097/JTO.0b013e31822a35c3.

19.

ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.

Skov BG, Holm B, Erreboe A, Skov T, Mellemgaard A.

J Thorac Oncol. 2010 Apr;5(4):453-9. doi: 10.1097/JTO.0b013e3181ca063b.

20.

Radical mediastinal nodal removal improves disease-free survival for pulmonary low-grade malignant tumors.

Zheng H, Xie HK, Li C, Bao F, Ding JA, Jiang GN, Zhang RX, Chen C.

Lung Cancer. 2012 Mar;75(3):342-7. doi: 10.1016/j.lungcan.2011.07.016. Epub 2011 Aug 15.

PMID:
21840617

Supplemental Content

Support Center